Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armodafinil for Cognition in Schizophrenia
NCT00373672Phase 4Completed
- Sponsor
- Northwestern University
- Start
- Aug 2006
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of armodafinil in schizophrenia, schizoaffective disorder, sponsored by Northwestern University. Started Aug 2006; status: completed.
02
Drugs
armodafinil
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00373672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00373672.